Adaptability at a protein-DNA interface: Re-engineering the engrailed homeodomain to recognize an unnatural nucleotide

Journal of the American Chemical Society

Volumn 126, Issue 26, 2004, Pages 8078-8079

  Simon, Matthew D ^a   Shokat, Kevan M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; NUCLEOTIDE;

ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; DNA STRAND; GEL MOBILITY SHIFT ASSAY; MOLECULAR MODEL; PROTEIN DNA INTERACTION; PROTEIN ENGINEERING;

BASE SEQUENCE; BINDING SITES; DNA-BINDING PROTEINS; ESCHERICHIA COLI; HOMEODOMAIN PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MUTAGENESIS, SITE-DIRECTED; NUCLEOTIDES; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS;

EID: 3042770584     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja048113w     Document Type: Article

References (21)

1. For a discussion of antibody plasticity, see: (a) Yin, J.; Beuscher, A. E.; Andryski, S. E.; Stevens, R. C.; Schultz, P. G. J. Mol. Biol. 2003, 330, 651-656.
2. For a review see: (b) Schultz, P. G.; Yin, J.; Lerner, R. A. Angew Chem., Int. Ed. 2002, 41, 4427-4437.
3. For examples of protein-protein interface remodeling see: (c) Atwell, S.; Ultsch, M.; DeVos, A. M.; Wells, J. A. Science 1997, 278; 1125-1128
4. and (d) Hiipakka, M.; Poikonen, K.; Saksela, K. J. Mol. Biol. 1999, 293, 1097-1106.
5. For examples and reviews, see: (a) Greisman, H. A.; Pabo, C. O. Science 1997, 275, 657-661.
6. (b) Segal, D. J.; Beerli, R. R.; Blancafort, P.; Dreier, B.; Effertz, K.; Huber, A.; Koksch, B.; Lund, C. V.; Magnenat, L.; Valente, D.; Barbas, C. F. Biochemistry 2003, 42, 2137-2148.
7. (c) Beerli, R. R.; Barbas, C. F. Nat. Biotechnol. 2002, 20, 135-141.
8. (d) Jamieson, A. C.; Miller, J. C.; Pabo, C. O. Nat. Rev. Drug Discov. 2003, 2, 361-368.
9. For a review, see: (a) Gehring, W. J.; Qian, Y. Q.; Billeter, M.; Furukubotokunaga, K.; Schier, A. F.; Resendezperez, D.; Affolter, M.; Otting, G.; Wuthrich, K. Cell 1994, 78, 211-223.
10. For discussion of the molecular evolution of HDs, see (b) Banerjee-Basu, S.; Baxevanis, A. D. Nucleic Acids Res. 2001, 29, 3258-3269.
11. TuckerKellogg, L.; Rould, M. A.; Chambers, K. A.; Ades, S. E.; Sauer, R. T.; Pabo, C. O. Structure 1997, 5, 1047-1054.
12. (a) Ades, S. E.; Sauer, R. T. Biochemistry 1994, 33, 9187-9194.
13. (b) Ades, S. E.; Sauer, R. T. Biochemistry 1995, 34, 14601-14608.
14. Wild-type engrailed HD binds the palindromic DNA sequence, TAATTA, thereby complicating the interpretation of biochemical experiments. To avoid this difficulty, we chose to work with the Q50K mutant which binds TAATCC.
15. See: He, J. L.; Seela, F. Nucleic Acids Res. 2002, 30, 5485-5496 and references therein.
16. See Supporting Information.
17. Cormack, B. P.; Struhl, K. Science 1993, 262, 244-248.
18. Simon, M. D.; Sato K.; Weiss G.; Shokat, K. M. Manuscript submitted.
19. For examples of other approaches to engineer small-molecule control over protein-protein and protein-DNA interactions, see: (a) Arndt, H. D.; Hauschild, K. E.; Sullivan, D. P.; Lake, K.; Dervan, P. B.; Ansari, A. Z. J. Am. Chem. Soc. 2003, 125, 13322-13323.
20. (b) Lin, Q.; Barbas, C. F.; Schultz, P. G. J. Am. Chem. Soc. 2003, 125, 612-613.
21. (c) Guo, Z. H.; Zhou, D. M.; Schultz, P. G. Science 2000, 288, 2042-2045.